Nitrosigine is a branded inositol-stabilized arginine silicate ingredient. Human research supports interest in its vascular effects, but a change in a blood-vessel test is not proof of greater strength, muscle growth, or faster recovery. Its value depends on which claim you are assessing.
Affiliate disclosure: We may earn a commission from purchases through the commercial links in this article.
A closer look at the blood flow study
A 2020 randomized crossover trial enrolled 24 healthy, physically active young adults; 21 completed all three conditions. Participants received 1.5 g Nitrosigine, 8 g citrulline malate, or placebo. Researchers assessed brachial-artery flow-mediated dilation before supplementation and after a 60-minute digestion period.
Both ingredients improved the dilation response relative to placebo, with no significant difference between them. This was a vascular measurement, not a resistance-training performance test. It did not show that 1.5 g Nitrosigine equals 8 g citrulline malate for repetitions, recovery, or muscle growth.
The participants were young and healthy, and certain medical conditions and medications were excluded. The study received public/university research funding; Nutrition21 funded publication costs through an unrestricted grant and was reported to have no other involvement. That context is useful when judging how broadly the result applies.
What about focus?
Two small cognitive studies published in 2016 used 1,500 mg daily and Trail Making Tests in healthy men. They found improvements on some measures, including a placebo-adjusted improvement after an acute dose in one study. Several authors were affiliated with Nutrition21.
Completing a cognitive test faster is a narrower finding than sustained workout focus or a better mind-muscle connection. It does not establish that a multi-ingredient pre-workout improves technique, motivation, or training safety. More independent research in realistic training settings would help answer those questions.
Finding it on a product label
The manufacturer’s Mother Bucker details list 1,500 mg Nitrosigine and 400 mg total caffeine per serving. Matching the ingredient amount used in one study does not validate the entire blend.
The LFG Burn listing also identifies Nitrosigine and lists 300 mg caffeine. Read the LFG Burn product details for the exact serving and current warnings. Neither a Nitrosigine study nor a “thermogenic” label alone demonstrates meaningful fat loss from the finished product.
The FDA caffeine guidance cites 400 mg daily as an amount not generally associated with negative effects for most adults. That is not a recommended single dose or a personal safety guarantee. Other caffeine sources count, and sensitivity varies.
Study amounts are not stacking instructions
The frequently cited 1.5 g amount is a research dose, not a reason to add multiple products until you reach it. A scoop may also contain stimulants, beta-alanine, and other compounds. Reducing or increasing the scoop changes all those amounts together.
There is also no basis here to promise that adding citrulline, glycerol, or creatine will amplify Nitrosigine’s effects. A study comparing ingredients separately does not test their combination. Judge each proposed combination on evidence for the combination and the complete label.
Safety and realistic expectations
Small, short studies cannot rule out uncommon side effects or establish long-term safety across all users. Do not interpret warmth, tingling, or other sensations as proof of greater circulation. If a reaction concerns you, stop use and seek medical advice rather than escalating the dose.
Discuss the full formula with a clinician or pharmacist if you use medication, particularly for cardiovascular conditions. FDA supplement guidance explains why product availability does not mean FDA has approved its safety or effectiveness.
Check the retailer offer for current terms. Confirm the final total and any recurring commitment; no fixed discount is promised.
Nitrosigine has a more specific research story than a generic pump slogan. The defensible conclusion is that preliminary vascular and cognitive findings merit attention, while broad performance and recovery guarantees exceed what these studies measured.
